All Cosmos Bio-Tech Holding Corporation (TPE:4148)
Taiwan · Delayed Price · Currency is TWD 32.30
-0.20 (-0.62%)
Jun 4, 2026, 9:34 AM CST
TPE:4148 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,929 | 2,949 | 2,459 | 2,827 | 3,702 | 2,197 | |
Revenue Growth (YoY) | 17.95% | 19.95% | -13.02% | -23.65% | 68.49% | 33.76% |
Cost of Revenue | 2,113 | 2,120 | 1,790 | 2,239 | 2,565 | 1,603 |
Gross Profit | 816.08 | 829.47 | 668.59 | 587.98 | 1,138 | 594.37 |
Selling, General & Admin | 523.78 | 521.56 | 501.14 | 396.35 | 475.57 | 377.78 |
Research & Development | 4.51 | 4.25 | 3.74 | 3.73 | 2.28 | 3.85 |
Operating Expenses | 532.04 | 532.88 | 512.71 | 398.08 | 470.58 | 321.12 |
Operating Income | 284.04 | 296.59 | 155.88 | 189.9 | 666.99 | 273.24 |
Interest Expense | -15.61 | -14.53 | -6.08 | -3.98 | -18.81 | -4.54 |
Interest & Investment Income | 23 | 22.7 | 35.23 | 30.42 | 11.49 | 9.43 |
Earnings From Equity Investments | 6.21 | 4.81 | 2.81 | 5.35 | 1.93 | 1.69 |
Currency Exchange Gain (Loss) | -17.67 | -17.67 | 38.38 | 39.24 | -41.87 | 21.82 |
Other Non Operating Income (Expenses) | 15.44 | 4.92 | 18.26 | -5.61 | 12.35 | 20.06 |
EBT Excluding Unusual Items | 295.41 | 296.81 | 244.48 | 255.31 | 632.08 | 321.7 |
Impairment of Goodwill | - | - | -0.8 | - | - | - |
Gain (Loss) on Sale of Investments | 3.01 | 3.01 | 2.07 | 2.74 | 1.9 | - |
Gain (Loss) on Sale of Assets | -2.56 | -2.56 | 1.2 | -0.42 | -0.03 | -0.12 |
Other Unusual Items | 0.1 | 0.1 | 5.81 | - | - | - |
Pretax Income | 295.97 | 297.37 | 252.77 | 257.63 | 633.95 | 321.59 |
Income Tax Expense | 96.71 | 91.14 | 78.28 | 68.32 | 177.93 | 84.93 |
Earnings From Continuing Operations | 199.26 | 206.23 | 174.49 | 189.31 | 456.02 | 236.65 |
Minority Interest in Earnings | -54.07 | -53.23 | -45.9 | -49.95 | -87.82 | -38.53 |
Net Income | 145.19 | 153 | 128.59 | 139.36 | 368.2 | 198.13 |
Net Income to Common | 145.19 | 153 | 128.59 | 139.36 | 368.2 | 198.13 |
Net Income Growth | 28.29% | 18.98% | -7.73% | -62.15% | 85.84% | 141.02% |
Shares Outstanding (Basic) | 67 | 67 | 67 | 67 | 67 | 67 |
Shares Outstanding (Diluted) | 67 | 67 | 68 | 74 | 69 | 67 |
Shares Change (YoY) | - | -0.76% | -8.64% | 7.16% | 2.86% | 0.14% |
EPS (Basic) | 2.16 | 2.28 | 1.91 | 2.07 | 5.48 | 2.95 |
EPS (Diluted) | 2.16 | 2.27 | 1.85 | 2.03 | 5.38 | 2.94 |
EPS Growth | 28.23% | 22.79% | -8.87% | -62.30% | 82.82% | 141.42% |
Free Cash Flow | 364.36 | 210.15 | -85.51 | 796.49 | -16.92 | -171.35 |
Free Cash Flow Per Share | 5.42 | 3.12 | -1.26 | 10.72 | -0.24 | -2.54 |
Dividend Per Share | 1.000 | 1.000 | 0.476 | 0.952 | 2.381 | 1.429 |
Dividend Growth | 110.00% | 110.00% | -50.00% | -60.00% | 66.67% | 50.00% |
Gross Margin | 27.86% | 28.13% | 27.19% | 20.80% | 30.73% | 27.05% |
Operating Margin | 9.70% | 10.06% | 6.34% | 6.72% | 18.02% | 12.44% |
Profit Margin | 4.96% | 5.19% | 5.23% | 4.93% | 9.95% | 9.02% |
Free Cash Flow Margin | 12.44% | 7.13% | -3.48% | 28.18% | -0.46% | -7.80% |
EBITDA | 340.22 | 352.59 | 199.16 | 230.19 | 709.9 | 315.03 |
EBITDA Margin | 11.62% | 11.96% | 8.10% | 8.14% | 19.17% | 14.34% |
D&A For EBITDA | 56.18 | 56 | 43.28 | 40.29 | 42.9 | 41.79 |
EBIT | 284.04 | 296.59 | 155.88 | 189.9 | 666.99 | 273.24 |
EBIT Margin | 9.70% | 10.06% | 6.34% | 6.72% | 18.02% | 12.44% |
Effective Tax Rate | 32.67% | 30.65% | 30.97% | 26.52% | 28.07% | 26.41% |